bioAffinity Technologies, Inc. Common Stock, Convertible, Conversion Price, Decrease
bioAffinity Technologies, Inc. (BIAF) reported Common Stock, Convertible, Conversion Price, Decrease of $3.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockConvertibleConversionPriceDecrease · last filed 2026-08-07
- bioAffinity Technologies, Inc. common stock, convertible, conversion price, decrease for the quarter ending 2026-03-31 was $3.00.
- bioAffinity Technologies, Inc. common stock, convertible, conversion price, decrease for fiscal 2025 was $0.10.
| Period end | Common Stock, Convertible, Conversion Price, Decrease 3 month | Common Stock, Convertible, Conversion Price, Decrease 6 month | Common Stock, Convertible, Conversion Price, Decrease 12 month |
|---|---|---|---|
| 2026-06-30 | $3.00 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $3.00 10-Q · filed 2026-05-11 | ||
| 2025-12-31 | $0.10 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |